-
CompareTheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)Catalog #: G4LP3-22500
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
CompareTheraPEAK® P3 Primary Cell Nucleofector® Solution Set (126 mL + 28 mL)Catalog #: G4LP3-126000
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
CompareDonorPlex™ Pooled Donor Human Hepatocytes, 50 Donor, Mixed GenderCatalog #: HUCS50PPooled 50-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.Sales unit: Ampule
-
CompareDonorPlexTM Pooled Donor Human Hepatocytes, 10 Donor, FemaleCatalog #: HUCS10PFPooled 10-donor female only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.Sales unit: Ampule
-
CompareDonorPlexTM Pooled Donor Human Hepatocytes, 20 Donor, FemaleCatalog #: HUCS20PFPooled 20-donor, female only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.Sales unit: Ampule
-
CompareDonorPlexTM Pooled Donor Human Hepatocytes, 10 Donor, MaleCatalog #: HUCS10PM
Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Sales unit: Ampule -
CompareDonorPlexTM Pooled Donor Human Hepatocytes, 10 donor, mixed genderCatalog #: HUCS10P
Pooled 10-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Sales unit: Ampule -
CompareDonorPlexTM Pooled Donor Human Hepatocytes, 20 Donor, MaleCatalog #: HUCS20PM
Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Sales unit: Ampule
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Synthego_Lonza_Protocol_Genome Editing of Resting T cellsTechnical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
PBMC Based T Cell Proliferation AssayProtocol instructions
-
Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T CellsInstructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
-
Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCsProtocol for DC and T Cell Assay from Matched PBMCs
-
Large-scale editing of human T cells -
Case Study – Improving the Expansion of Patients' T CellsIn this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
-
Synthego-Lonza Genome Editing of Resting T cellsCase Study on Genome Editing of Resting T cells
-
A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell ExpansionThis poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.